Tapewire

Nasdaq · USD

SVRA

Savara Inc

Export transactions ↓
Tapewire entity
4900
SEC CIK
0001160308
Parsed reports
230

Last 12 months

Inside the activity.

0 purchase rows · 2 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202501
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202601
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
March 15, 2021 Filed Mar 15, 2021 18:44 UTC PurchaseCommon Stock 689,655 $1.45 $999,999.75
Disclosure

SEC source: 0001209191-21-020414 · doc4.xml · nonDerivative · entry 1

RAMSAY DAVID A · CIK 0001283292 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 811,797

Read SEC document
March 15, 2021 Filed Mar 15, 2021 18:46 UTC PurchaseCommon Stock 68,965 $1.45 $99,999.25
Disclosure

SEC source: 0001209191-21-020415 · doc4.xml · nonDerivative · entry 1

McCracken Joseph S · CIK 0001632454 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 168,337

Read SEC document
February 22, 2021 Filed Feb 23, 2021 14:48 UTC
Pauls MatthewDirector · CHIEF EXECUTIVE OFFICER
PurchaseCommon Stock 28,700 $1.74 $50,038.45
Disclosure

SEC source: 0001209191-21-013062 · doc4.xml · nonDerivative · entry 1

Pauls Matthew · CIK 0001573429 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 256,622

F1 · shares: The purchases reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 31, 2020.

F2 · price: The price is a weighted average purchase price. The purchase prices ranged from $1.73 to $1.80. The reporting person undertakes to provide Savara Inc., any security holder of Savara Inc., or the staff of the Securities and Exchange Commission, upon receipt of a request, full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.

Read SEC document
December 16, 2020 Filed Dec 18, 2020 01:15 UTC
Sun RickyDirector
GrantStock Option (Right to Buy) · Derivative 40,000 $0.00 Strike: $1.23 $0.00
Disclosure

SEC source: 0000899243-20-034330 · doc4.xml · derivative · entry 1

Sun Ricky · CIK 0001790589 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,000

Underlying: Common Stock · 40,000 shares

Expires 2030-12-16

F1 · derivative.exercise_date: The shares subject to the option vest and become exercisable on December 16, 2021.

Read SEC document
December 16, 2020 Filed Dec 17, 2020 17:37 UTC
Lowrance David LCHIEF FINANCIAL OFFICER
GrantStock Option (Right to Buy) · Derivative 260,000 $0.00 Strike: $1.23 $0.00
Disclosure

SEC source: 0001209191-20-063984 · doc4.xml · derivative · entry 1

Lowrance David L · CIK 0001408498 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 260,000

Underlying: Common Stock · 260,000 shares

Expires 2020-12-16

F1 · derivative.exercise_date: The option vests and becomes exercisable in sixteen equal installments on each quarterly anniversary of December 16, 2020, subject to the reporting person's continued service with the Issuer.

Read SEC document
December 16, 2020 Filed Dec 17, 2020 17:35 UTC
Chowdhury Badrul A.CHIEF MEDICAL OFFICER
GrantStock Option (Right to Buy) · Derivative 275,000 $0.00 Strike: $1.23 $0.00
Disclosure

SEC source: 0001209191-20-063982 · doc4.xml · derivative · entry 1

Chowdhury Badrul A. · CIK 0001776662 · CHIEF MEDICAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 275,000

Underlying: Common Stock · 275,000 shares

Expires 2030-12-16

F1 · derivative.exercise_date: The option vests and becomes exercisable in sixteen equal installments on each quarterly anniversary of December 16, 2020, subject to the reporting person's continued service with the Issuer.

Read SEC document
December 16, 2020 Filed Dec 17, 2020 17:34 UTC
Pauls MatthewDirector · CHIEF EXECUTIVE OFFICER
GrantStock Option (Right to Buy) · Derivative 500,000 $0.00 Strike: $1.23 $0.00
Disclosure

SEC source: 0001209191-20-063981 · doc4.xml · derivative · entry 1

Pauls Matthew · CIK 0001573429 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 500,000

Underlying: Common Stock · 500,000 shares

Expires 2030-12-16

F1 · derivative.exercise_date: The option vests and becomes exercisable in sixteen equal installments on each quarterly anniversary of December 16, 2020, subject to the reporting person's continued service with the Issuer.

Read SEC document
December 16, 2020 Filed Dec 17, 2020 17:31 UTC GrantStock Option (Right to Buy) · Derivative 40,000 $0.00 Strike: $1.23 $0.00
Disclosure

SEC source: 0001209191-20-063978 · doc4.xml · derivative · entry 1

McCracken Joseph S · CIK 0001632454 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,000

Underlying: Common Stock · 40,000 shares

Expires 2030-12-16

F1 · derivative.exercise_date: The shares subject to the option vest and become exercisable on December 16, 2021.

Read SEC document
December 16, 2020 Filed Dec 17, 2020 17:21 UTC GrantStock Option (Right to Buy) · Derivative 40,000 $0.00 Strike: $1.23 $0.00
Disclosure

SEC source: 0001209191-20-063977 · doc4.xml · derivative · entry 1

RAMSAY DAVID A · CIK 0001283292 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,000

Underlying: Common Stock · 40,000 shares

Expires 2030-12-16

F1 · derivative.exercise_date: The shares subject to the option vest and become exercisable on December 16, 2021.

Read SEC document
December 16, 2020 Filed Dec 17, 2020 17:19 UTC GrantStock Option (Right to Buy) · Derivative 40,000 $0.00 Strike: $1.23 $0.00
Disclosure

SEC source: 0001209191-20-063976 · doc4.xml · derivative · entry 1

van Es-Johansson An · CIK 0001795902 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,000

Underlying: Common Stock · 40,000 shares

Expires 2030-12-16

F1 · derivative.exercise_date: The shares subject to the option vest and become exercisable on December 16, 2021.

Read SEC document
December 16, 2020 Filed Dec 17, 2020 17:17 UTC GrantStock Option (Right to Buy) · Derivative 40,000 $0.00 Strike: $1.23 $0.00
Disclosure

SEC source: 0001209191-20-063975 · doc4.xml · derivative · entry 1

Hawkins Richard J · CIK 0001307632 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,000

Underlying: Common Stock · 40,000 shares

Expires 2030-12-16

F1 · derivative.exercise_date: The shares subject to the option vest and become exercisable on December 16, 2021.

Read SEC document
December 16, 2020 Filed Dec 17, 2020 17:13 UTC
Elam Nevan CDirector
GrantStock Option (Right to Buy) · Derivative 40,000 $0.00 Strike: $1.23 $0.00
Disclosure

SEC source: 0001209191-20-063973 · doc4.xml · derivative · entry 3

Elam Nevan C · CIK 0001314773 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,000

Underlying: Common Stock · 40,000 shares

Expires 2030-12-16

F2 · derivative.exercise_date: The shares subject to the option vest and become exercisable on December 16, 2021.

Read SEC document
December 15, 2020 Filed Dec 17, 2020 17:13 UTC
Elam Nevan CDirector
Exercise / conversionStock Option (Right to Buy) · Derivative 2,930 $0.00 Strike: $0.52 $0.00
Disclosure

SEC source: 0001209191-20-063973 · doc4.xml · derivative · entry 2

Elam Nevan C · CIK 0001314773 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,930 shares

Expires 2020-12-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The shares subject to the option vested and became exercisable in twelve equal quarterly installments beginning on March 17, 2011.

Read SEC document
December 15, 2020 Filed Dec 17, 2020 17:13 UTC
Elam Nevan CDirector
Exercise / conversionCommon Stock 2,930 $0.52 $1,523.60
Disclosure

SEC source: 0001209191-20-063973 · doc4.xml · nonDerivative · entry 1

Elam Nevan C · CIK 0001314773 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,612

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 15, 2020 Filed Sep 16, 2020 01:45 UTC
Pauls MatthewDirector · See Remarks
GrantStock Option (Right to Buy) · Derivative 898,639 $0.00 Strike: $1.32 $0.00
Disclosure

SEC source: 0000899243-20-025225 · doc4.xml · derivative · entry 4

Pauls Matthew · CIK 0001573429 · Director · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 898,639

Underlying: Common Stock · 898,639 shares

Expires 2030-09-15

F5 · derivative.exercise_date: The shares subject to the option vest and become exercisable in thirty-six equal installments on each monthly anniversary of September 11, 2020, subject to the reporting person's continued service with the Issuer.

Read SEC document
September 15, 2020 Filed Sep 16, 2020 01:45 UTC
Pauls MatthewDirector · See Remarks
GrantCommon Stock 227,272 $0.00 $0.00
Disclosure

SEC source: 0000899243-20-025225 · doc4.xml · nonDerivative · entry 2

Pauls Matthew · CIK 0001573429 · Director · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 227,922

F2 · shares: Represents RSUs that vest in full on the earlier to occur of (i) December 31, 2021 or (ii) the hiring of a permanent Chief Executive Officer of the Issuer, subject to the reporting person's continued service with the Issuer. Each RSU represents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
March 10, 2020 Filed Mar 17, 2020 21:43 UTC
Sun RickyDirector
GrantStock Option (Right to Buy) · Derivative 12,000 $0.00 Strike: $2.55 $0.00
Disclosure

SEC source: 0000899243-20-008648 · doc4.xml · derivative · entry 1

Sun Ricky · CIK 0001790589 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,000

Underlying: Common Stock · 12,000 shares

Expires 2030-03-10

F1 · derivative.exercise_date: The shares subject to the option vest quarterly over 3 years from Dr. Sun's appointment as a director of the Issuer, subject to Dr. Sun's continued service with the Issuer.

Read SEC document
December 20, 2019 Filed Dec 26, 2019 23:00 UTC GrantStock Option (Right to Buy) · Derivative 12,000 $0.00 Strike: $1.59 $0.00
Disclosure

SEC source: 0000899243-19-030068 · doc4.xml · derivative · entry 1

van Es-Johansson An · CIK 0001795902 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,000

Underlying: Common Stock · 12,000 shares

Expires 2029-12-20

F1 · derivative.exercise_date: The shares subject to the option vest and become exercisable in twelve equal installments on each quarterly anniversary of December 20, 2019, subject to the reporting person's continued service with the Issuer.

Read SEC document
December 20, 2019 Filed Dec 26, 2019 23:05 UTC
Lowrance David LChief Financial Officer
GrantStock Option (Right to Buy) · Derivative 150,000 $0.00 Strike: $1.59 $0.00
Disclosure

SEC source: 0000899243-19-030076 · doc4.xml · derivative · entry 1

Lowrance David L · CIK 0001408498 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 150,000

Underlying: Common Stock · 150,000 shares

Expires 2029-12-20

F1 · derivative.exercise_date: The option vests and becomes exercisable in sixteen equal installments on each quarterly anniversary of December 20, 2019, subject to the reporting person's continued service with the Issuer.

Read SEC document
December 20, 2019 Filed Dec 26, 2019 23:05 UTC GrantStock Option (Right to Buy) · Derivative 12,000 $0.00 Strike: $1.59 $0.00
Disclosure

SEC source: 0000899243-19-030075 · doc4.xml · derivative · entry 1

RAMSAY DAVID A · CIK 0001283292 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,000

Underlying: Common Stock · 12,000 shares

Expires 2029-12-20

F1 · derivative.exercise_date: The shares subject to the option vest and become exercisable in twelve equal installments on each quarterly anniversary of December 20, 2019, subject to the reporting person's continued service with the Issuer.

Read SEC document
December 20, 2019 Filed Dec 26, 2019 23:04 UTC GrantStock Option (Right to Buy) · Derivative 12,000 $0.00 Strike: $1.59 $0.00
Disclosure

SEC source: 0000899243-19-030074 · doc4.xml · derivative · entry 1

Hawkins Richard J · CIK 0001307632 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,000

Underlying: Common Stock · 12,000 shares

Expires 2029-12-20

F1 · derivative.exercise_date: The shares subject to the option vest and become exercisable in twelve equal installments on each quarterly anniversary of December 20, 2019, subject to the reporting person's continued service with the Issuer.

Read SEC document
December 20, 2019 Filed Dec 26, 2019 23:03 UTC GrantStock Option (Right to Buy) · Derivative 12,000 $0.00 Strike: $1.59 $0.00
Disclosure

SEC source: 0000899243-19-030072 · doc4.xml · derivative · entry 1

Pauls Matthew · CIK 0001573429 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,000

Underlying: Common Stock · 12,000 shares

Expires 2029-12-20

F1 · derivative.exercise_date: The shares subject to the option vest and become exercisable in twelve equal installments on each quarterly anniversary of December 20, 2019, subject to the reporting person's continued service with the Issuer.

Read SEC document
December 20, 2019 Filed Dec 26, 2019 23:03 UTC GrantStock Option (Right to Buy) · Derivative 200,000 $0.00 Strike: $1.59 $0.00
Disclosure

SEC source: 0000899243-19-030071 · doc4.xml · derivative · entry 1

Jouhikainen Jaakko Taneli · CIK 0001703641 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 200,000

Underlying: Common Stock · 200,000 shares

Expires 2029-12-20

F1 · derivative.exercise_date: The option vests and becomes exercisable in sixteen equal installments on each quarterly anniversary of December 20, 2019, subject to the reporting person's continued service with the Issuer.

Read SEC document
December 20, 2019 Filed Dec 26, 2019 23:01 UTC
Neville Robert NDirector · Chief Executive Officer
GrantStock Option (Right to Buy) · Derivative 200,000 $0.00 Strike: $1.59 $0.00
Disclosure

SEC source: 0000899243-19-030070 · doc4.xml · derivative · entry 1

Neville Robert N · CIK 0001703487 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 200,000

Underlying: Common Stock · 200,000 shares

Expires 2029-12-20

F1 · derivative.exercise_date: The option vests and becomes exercisable in sixteen equal installments on each quarterly anniversary of December 20, 2019, subject to the reporting person's continued service with the Issuer.

Read SEC document
December 20, 2019 Filed Dec 26, 2019 23:00 UTC
Elam Nevan CDirector
GrantStock Option (Right to Buy) · Derivative 12,000 $0.00 Strike: $1.59 $0.00
Disclosure

SEC source: 0000899243-19-030069 · doc4.xml · derivative · entry 1

Elam Nevan C · CIK 0001314773 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,000

Underlying: Common Stock · 12,000 shares

Expires 2029-12-20

F1 · derivative.exercise_date: The shares subject to the option vest and become exercisable in twelve equal installments on each quarterly anniversary of December 20, 2019, subject to the reporting person's continued service with the Issuer.

Read SEC document
December 20, 2019 Filed Dec 26, 2019 23:00 UTC GrantStock Option (Right to Buy) · Derivative 12,000 $0.00 Strike: $1.59 $0.00
Disclosure

SEC source: 0000899243-19-030067 · doc4.xml · derivative · entry 1

McCracken Joseph S · CIK 0001632454 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,000

Underlying: Common Stock · 12,000 shares

Expires 2029-12-20

F1 · derivative.exercise_date: The shares subject to the option vest and become exercisable in twelve equal installments on each quarterly anniversary of December 20, 2019, subject to the reporting person's continued service with the Issuer

Read SEC document
November 26, 2019 Filed Nov 27, 2019 21:10 UTC
Chowdhury Badrul A.Chief Medical Officer
GrantRestricted Stock Units · Derivative 200,000 $0.00 $0.00
Disclosure

SEC source: 0000899243-19-028226 · doc4.xml · derivative · entry 2

Chowdhury Badrul A. · CIK 0001776662 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 200,000

Underlying: Common Stock · 200,000 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

F3 · derivative.exercise_date: The restricted stock units shall vest in full on the eighteen (18) month anniversary of November 15, 2019, subject to the reporting person's continued service with the Issuer. Vested shares will be delivered to the reporting person on the first date that is administratively practicable following the date on which such unit becomes vested.

F3 · derivative.expiration_date: The restricted stock units shall vest in full on the eighteen (18) month anniversary of November 15, 2019, subject to the reporting person's continued service with the Issuer. Vested shares will be delivered to the reporting person on the first date that is administratively practicable following the date on which such unit becomes vested.

Read SEC document
November 26, 2019 Filed Nov 27, 2019 21:10 UTC
Chowdhury Badrul A.Chief Medical Officer
GrantStock Option (Right to Buy) · Derivative 300,000 $0.00 Strike: $1.01 $0.00
Disclosure

SEC source: 0000899243-19-028226 · doc4.xml · derivative · entry 1

Chowdhury Badrul A. · CIK 0001776662 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 300,000

Underlying: Common Stock · 300,000 shares

Expires 2029-11-26

F1 · derivative.exercise_date: The shares subject to the option vest and become exercisable in sixteen equal installments on each quarterly anniversary of November 15, 2019, subject to the reporting person's continued service with the Issuer.

Read SEC document
July 05, 2019 Filed Jul 8, 2019 20:05 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 9,034 $0.00 Strike: $1.76 $0.00
Disclosure

SEC source: 0000899243-19-019303 · doc4.xml · derivative · entry 8

McCracken Joseph S · CIK 0001632454 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,807

Underlying: Common Stock · 9,034 shares

Expires 2026-12-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The shares subject to the option vest and become exercisable in twelve equal quarterly installments beginning on March 15, 2017.

Read SEC document
July 05, 2019 Filed Jul 8, 2019 20:05 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 5,860 $0.00 Strike: $1.46 $0.00
Disclosure

SEC source: 0000899243-19-019303 · doc4.xml · derivative · entry 7

McCracken Joseph S · CIK 0001632454 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,860 shares

Expires 2025-12-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The shares subject to the option vested and became exercisable in twelve equal quarterly installments beginning on March 15, 2016.

Read SEC document
July 05, 2019 Filed Jul 8, 2019 20:05 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 2,930 $0.00 Strike: $0.82 $0.00
Disclosure

SEC source: 0000899243-19-019303 · doc4.xml · derivative · entry 6

McCracken Joseph S · CIK 0001632454 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,930 shares

Expires 2024-07-24

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The shares subject to the option vested and became exercisable in twelve equal quarterly installments beginning on October 24, 2014.

Read SEC document
July 05, 2019 Filed Jul 8, 2019 20:05 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 21,682 $0.00 Strike: $0.82 $0.00
Disclosure

SEC source: 0000899243-19-019303 · doc4.xml · derivative · entry 5

McCracken Joseph S · CIK 0001632454 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 21,682 shares

Expires 2023-11-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The shares subject to the option vested and became exercisable in twelve equal quarterly installments beginning on January 15, 2014.

Read SEC document
July 05, 2019 Filed Jul 8, 2019 20:05 UTC Exercise / conversionCommon Stock 9,034 $1.76 $15,899.84
Disclosure

SEC source: 0000899243-19-019303 · doc4.xml · nonDerivative · entry 4

McCracken Joseph S · CIK 0001632454 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 99,372

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 05, 2019 Filed Jul 8, 2019 20:05 UTC Exercise / conversionCommon Stock 5,860 $1.46 $8,555.60
Disclosure

SEC source: 0000899243-19-019303 · doc4.xml · nonDerivative · entry 3

McCracken Joseph S · CIK 0001632454 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 90,338

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 05, 2019 Filed Jul 8, 2019 20:05 UTC Exercise / conversionCommon Stock 2,930 $0.82 $2,402.60
Disclosure

SEC source: 0000899243-19-019303 · doc4.xml · nonDerivative · entry 2

McCracken Joseph S · CIK 0001632454 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 84,478

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 05, 2019 Filed Jul 8, 2019 20:05 UTC Exercise / conversionCommon Stock 21,682 $0.82 $17,779.24
Disclosure

SEC source: 0000899243-19-019303 · doc4.xml · nonDerivative · entry 1

McCracken Joseph S · CIK 0001632454 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 81,548

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 28, 2019 Filed Jun 28, 2019 21:36 UTC PurchaseCommon Stock 5,000 $2.36 $11,800.00
Disclosure

SEC source: 0000899243-19-018545 · doc4.xml · nonDerivative · entry 9

RAMSAY DAVID A · CIK 0001283292 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 122,142

Read SEC document
June 28, 2019 Filed Jun 28, 2019 21:36 UTC PurchaseCommon Stock 12,157 $2.35 $28,568.95
Disclosure

SEC source: 0000899243-19-018545 · doc4.xml · nonDerivative · entry 8

RAMSAY DAVID A · CIK 0001283292 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 117,142

Read SEC document
June 28, 2019 Filed Jun 28, 2019 21:36 UTC PurchaseCommon Stock 18,000 $2.33 $41,940.00
Disclosure

SEC source: 0000899243-19-018545 · doc4.xml · nonDerivative · entry 7

RAMSAY DAVID A · CIK 0001283292 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 104,985

Read SEC document
June 27, 2019 Filed Jun 28, 2019 21:36 UTC PurchaseCommon Stock 2,300 $2.38 $5,474.00
Disclosure

SEC source: 0000899243-19-018545 · doc4.xml · nonDerivative · entry 6

RAMSAY DAVID A · CIK 0001283292 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 86,985

Read SEC document
June 27, 2019 Filed Jun 28, 2019 21:36 UTC PurchaseCommon Stock 5,000 $2.39 $11,950.00
Disclosure

SEC source: 0000899243-19-018545 · doc4.xml · nonDerivative · entry 5

RAMSAY DAVID A · CIK 0001283292 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 84,685

Read SEC document
June 27, 2019 Filed Jun 28, 2019 21:36 UTC PurchaseCommon Stock 5,000 $2.40 $12,000.00
Disclosure

SEC source: 0000899243-19-018545 · doc4.xml · nonDerivative · entry 4

RAMSAY DAVID A · CIK 0001283292 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 79,685

Read SEC document
June 27, 2019 Filed Jun 28, 2019 21:36 UTC PurchaseCommon Stock 5,000 $2.42 $12,100.00
Disclosure

SEC source: 0000899243-19-018545 · doc4.xml · nonDerivative · entry 3

RAMSAY DAVID A · CIK 0001283292 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 74,685

Read SEC document
June 27, 2019 Filed Jun 28, 2019 21:36 UTC PurchaseCommon Stock 5,000 $2.45 $12,250.00
Disclosure

SEC source: 0000899243-19-018545 · doc4.xml · nonDerivative · entry 2

RAMSAY DAVID A · CIK 0001283292 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 69,685

Read SEC document
June 26, 2019 Filed Jun 28, 2019 21:36 UTC PurchaseCommon Stock 900 $2.38 $2,142.00
Disclosure

SEC source: 0000899243-19-018545 · doc4.xml · nonDerivative · entry 1

RAMSAY DAVID A · CIK 0001283292 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 64,685

Read SEC document
June 18, 2019 Filed Jun 19, 2019 21:58 UTC PurchaseCommon Stock 10,215 $2.35 $24,005.25
Disclosure

SEC source: 0000899243-19-017457 · doc4.xml · nonDerivative · entry 6

RAMSAY DAVID A · CIK 0001283292 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 63,785

Read SEC document
June 18, 2019 Filed Jun 19, 2019 21:58 UTC PurchaseCommon Stock 5,000 $2.36 $11,800.00
Disclosure

SEC source: 0000899243-19-017457 · doc4.xml · nonDerivative · entry 5

RAMSAY DAVID A · CIK 0001283292 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,570

Read SEC document
June 17, 2019 Filed Jun 19, 2019 21:58 UTC PurchaseCommon Stock 5,000 $2.37 $11,850.00
Disclosure

SEC source: 0000899243-19-017457 · doc4.xml · nonDerivative · entry 4

RAMSAY DAVID A · CIK 0001283292 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,570

Read SEC document
June 17, 2019 Filed Jun 19, 2019 21:58 UTC PurchaseCommon Stock 10,000 $2.38 $23,800.00
Disclosure

SEC source: 0000899243-19-017457 · doc4.xml · nonDerivative · entry 3

RAMSAY DAVID A · CIK 0001283292 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,570

Read SEC document
June 17, 2019 Filed Jun 19, 2019 21:58 UTC PurchaseCommon Stock 10,000 $2.39 $23,900.00
Disclosure

SEC source: 0000899243-19-017457 · doc4.xml · nonDerivative · entry 2

RAMSAY DAVID A · CIK 0001283292 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,570

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.